Trial Profile
Randomized Trial of Erythropoietin to Prevent Death From Cerebral Impairment During Severe Malaria
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Acronyms EPOMAL
- 28 Feb 2017 New trial record